Company profile
LEI
cee stock exchange group
Issuers / Issuers News
Article print

13 Sep 2013 14:15 
Extraordinary Information
Marketing authorisation for biosimilar infliximab in EU
Attached documents:
Releaser: EGIS Pharmaceuticals PLC
Date Issued: 13 Sep 2013
 
Actual
2013 average
Name
Price
%
Turn. (mEUR)
^
760
+1.20
0
ˇ
185
-1.07
0
^
840
+1.20
0
ˇ
229
-0.43
0
-
5,700
0.00
0
ˇ
871
-1.14
0
^
13,135
+1.43
3
ˇ
313
-0.32
1
ˇ
4,330
-1.55
6
^
337
+0.30
0
^
1,305
+1.87
0
ˇ
3,790
-2.07
4
ˇ
190
-0.52
0
ˇ
4,003
-0.30
0
Change %: to baseprice
Data delayed by 15 minutes
Indices
Index
Value
Change %
BUX
17,774.54
-110.02 (-0.62)
1,520.73
8.94 (0.59)
1,223.99
-0.36 (-0.03)
1,207.18
-0.69 (-0.06)
1,890.69
15.11 (0.81)